• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者和对照组中胰岛素样生长因子1、嗜铬粒蛋白A和前列腺特异性抗原的血清水平。

Insulin-like growth factor 1, chromogranin A and prostate specific antigen serum levels in prostate cancer patients and controls.

作者信息

Marszalek Martin, Wachter Johann, Ponholzer Anton, Leitha Thomas, Rauchenwald Michael, Madersbacher Stephan

机构信息

Department of Urology and Andrology, Donauspital, Langobardenstrasse 122, A-1220 Vienna, Austria.

出版信息

Eur Urol. 2005 Jul;48(1):34-9. doi: 10.1016/j.eururo.2005.03.020. Epub 2005 Apr 2.

DOI:10.1016/j.eururo.2005.03.020
PMID:15967249
Abstract

OBJECTIVE

Insulin-like growth factor 1 (IGF-1) and chromogranin A (CGA) are currently discussed as supplemental serum markers for prostate cancer (PC) diagnosis. To address this issue we determined serum levels of IGF-1, CGA and PSA in men with newly diagnosed PC and controls.

METHODS

A consecutive series of 156 men (median age: 67 yrs) with newly diagnosed, untreated PC and 271 controls (69 yrs) were recruited. The diagnosis of PC was made by transrectal ultrasound guided biopsies only. In controls, the presence of PC was excluded by digito-rectal examination, serum prostate specific antigen (PSA) levels by using age-specific reference values and-if indicated-by transrectal ultrasound guided 12-core biopsies. Serum levels of IGF-1, CGA and PSA were compared between cases and controls and correlated to histopathological findings and age.

RESULTS

Serum PSA-levels were significantly higher in men with PC (49.6+/-13.9 ng/ml, mean+/-standard error of the mean; median: 7.0 ng/ml) than in controls (2.6+/-0.2 ng/ml; median: 1.3 ng/ml) (p<0.001). In contrast, serum levels of IGF-1 (PC: 166+/-6.1 ng/ml, median: 155 ng/ml; controls: 159+/-4.5 ng/ml, 153 ng/ml) and CGA (PC: 92+/-7.4 U/l, median: 67 U/l; controls: 117+/-12.0 U/l; median: 74 U/l) were identical in both groups (p>0.05). Serum levels of IGF-1 and CGA revealed no correlation to serum PSA, Gleason score and number of positive biopsy cores. In the PC-cohort all three serum markers did not correlate with age. In controls, PSA (p=0.018) and CGA (p<0.001) correlated positively and IGF-1 (p<0.001) negatively with age.

CONCLUSION

Our data suggest that quantification of IGF-1 and CGA-serum levels provides no useful information in the diagnosis of PC.

摘要

目的

胰岛素样生长因子1(IGF-1)和嗜铬粒蛋白A(CGA)目前被作为前列腺癌(PC)诊断的补充血清标志物进行讨论。为解决这一问题,我们测定了新诊断的PC患者及对照者血清中IGF-1、CGA和前列腺特异抗原(PSA)的水平。

方法

招募了连续的156例新诊断的未经治疗的PC患者(中位年龄:67岁)和271例对照者(69岁)。PC的诊断仅通过经直肠超声引导下的活检进行。在对照者中,通过直肠指检、使用年龄特异性参考值测定血清前列腺特异抗原(PSA)水平,必要时通过经直肠超声引导下的12针活检排除PC的存在。比较病例组和对照组血清中IGF-1、CGA和PSA的水平,并与组织病理学结果和年龄进行相关性分析。

结果

PC患者的血清PSA水平(49.6±13.9 ng/ml,平均值±平均标准误;中位值:7.0 ng/ml)显著高于对照组(2.6±0.2 ng/ml;中位值:1.3 ng/ml)(p<0.001)。相比之下,两组的血清IGF-1水平(PC组:166±6.1 ng/ml,中位值:155 ng/ml;对照组:159±4.5 ng/ml,153 ng/ml)和CGA水平(PC组:92±7.4 U/l,中位值:67 U/l;对照组:117±12.0 U/l;中位值:74 U/l)相同(p>0.05)。血清IGF-1和CGA水平与血清PSA、Gleason评分及阳性活检针数均无相关性。在PC队列中,所有三种血清标志物均与年龄无相关性。在对照组中,PSA(p=0.018)和CGA(p<0.001)与年龄呈正相关,而IGF-1(p<0.001)与年龄呈负相关。

结论

我们的数据表明,测定IGF-1和CGA的血清水平在PC诊断中并无有用信息。

相似文献

1
Insulin-like growth factor 1, chromogranin A and prostate specific antigen serum levels in prostate cancer patients and controls.前列腺癌患者和对照组中胰岛素样生长因子1、嗜铬粒蛋白A和前列腺特异性抗原的血清水平。
Eur Urol. 2005 Jul;48(1):34-9. doi: 10.1016/j.eururo.2005.03.020. Epub 2005 Apr 2.
2
Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.前列腺癌和良性前列腺增生患者体内的胰岛素样生长因子结合蛋白-2
Clin Endocrinol (Oxf). 1997 Mar;46(3):333-42.
3
Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasia.嗜铬粒蛋白A、胰岛素样生长因子1和前列腺特异性抗原血清标志物在前列腺腺癌和良性前列腺增生中的比较。
Urol Int. 2008;80(1):68-73. doi: 10.1159/000111733. Epub 2008 Jan 18.
4
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.嗜铬粒蛋白A在激素难治性前列腺癌患者中的独立预后作用。
Endocr Relat Cancer. 2005 Mar;12(1):109-17. doi: 10.1677/erc.1.00876.
5
Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.前列腺癌和良性前列腺增生患者体内的胰岛素样生长因子结合蛋白-2
Clin Endocrinol (Oxf). 1997 Feb;46(2):145-54.
6
Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.前列腺癌患者的血清胰岛素水平、疾病分期、前列腺特异性抗原(PSA)和 Gleason 评分。
Br J Cancer. 2002 Sep 23;87(7):726-8. doi: 10.1038/sj.bjc.6600526.
7
[Plasma chromogranin-A (CgA)--a potential marker for diagnosis, monitoring and management of prostate cancer patients].[血浆嗜铬粒蛋白A(CgA)——前列腺癌患者诊断、监测及管理的潜在标志物]
Harefuah. 2006 Jan;145(1):25-9, 78.
8
Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive value of serum chromogranin A.接受根治性前列腺切除术的前列腺腺癌患者的临床分期不足:血清嗜铬粒蛋白A的预测价值
Prostate. 2004 Mar 1;58(4):421-8. doi: 10.1002/pros.10347.
9
Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy.嗜铬粒蛋白A与接受根治性前列腺切除术的前列腺腺癌患者的生化无进展生存期
Endocr Relat Cancer. 2007 Sep;14(3):625-32. doi: 10.1677/ERC-07-0089.
10
IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.胰岛素样生长因子-II血清水平提高了前列腺增生与前列腺癌之间的鉴别能力,并改善了前列腺特异性抗原在临床分期中的预测价值。
Eur Urol. 2006 Feb;49(2):286-92; discussion 292. doi: 10.1016/j.eururo.2005.08.022. Epub 2005 Dec 7.

引用本文的文献

1
Prognostic value of circulating Chromogranin A in prostate cancer: a systematic review and meta-analysis.循环嗜铬粒蛋白A在前列腺癌中的预后价值:一项系统评价和荟萃分析。
Front Oncol. 2025 Feb 5;15:1521558. doi: 10.3389/fonc.2025.1521558. eCollection 2025.
2
Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target.胰岛素样生长因子-1在前列腺癌中的新作用:一种有前景的生物标志物和治疗靶点。
Cancers (Basel). 2023 Feb 17;15(4):1287. doi: 10.3390/cancers15041287.
3
Physical resistance training-induced changes in lipids metabolism pathways and apoptosis in prostate.
物理抵抗训练引起前列腺中脂质代谢途径和细胞凋亡的变化。
Lipids Health Dis. 2020 Jan 29;19(1):14. doi: 10.1186/s12944-020-1195-0.
4
Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis.摄入牛奶是否通过对胰岛素样生长因子(IGFs)的影响促进前列腺癌的发生或发展?一项系统综述和荟萃分析。
Cancer Causes Control. 2017 Jun;28(6):497-528. doi: 10.1007/s10552-017-0883-1. Epub 2017 Mar 30.
5
Characterization of reactive stroma in prostate cancer: involvement of growth factors, metalloproteinase matrix, sexual hormones receptors and prostatic stem cells.前列腺癌中反应性基质的特征:生长因子、金属蛋白酶基质、性激素受体及前列腺干细胞的作用
Int Braz J Urol. 2015 Sep-Oct;41(5):849-58. doi: 10.1590/S1677-5538.IBJU.2014.0355.
6
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and prostate cancer: correlation with Gleason score.胰岛素样生长因子(IGF)-I、IGF结合蛋白-3与前列腺癌:与 Gleason 评分的相关性
Int Braz J Urol. 2015 Jan-Feb;41(1):110-5. doi: 10.1590/S1677-5538.IBJU.2015.01.15.
7
Proliferative, structural and molecular features of the Mdx mouse prostate.Mdx 小鼠前列腺的增殖、结构和分子特征。
Int J Exp Pathol. 2010 Oct;91(5):408-19. doi: 10.1111/j.1365-2613.2010.00722.x.
8
Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.循环胰岛素样生长因子肽与前列腺癌风险:一项系统评价和荟萃分析。
Int J Cancer. 2009 May 15;124(10):2416-29. doi: 10.1002/ijc.24202.